BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18670086)

  • 1. Dexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expression.
    Wang K; Wang Y; Gao L; Li X; Li M; Guo J
    Biol Pharm Bull; 2008 Aug; 31(8):1541-6. PubMed ID: 18670086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
    Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.
    Miyahara S; Kiryu J; Yamashiro K; Miyamoto K; Hirose F; Tamura H; Katsuta H; Nishijima K; Tsujikawa A; Honda Y
    Am J Pathol; 2004 May; 164(5):1697-706. PubMed ID: 15111316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B; Sun JH; Xiang FF; Liu L; Li WJ
    Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF164 is proinflammatory in the diabetic retina.
    Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
    Hattori T; Matsubara A; Taniguchi K; Ogura Y
    Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.
    Xu X; Zhu Q; Xia X; Zhang S; Gu Q; Luo D
    Curr Eye Res; 2004 Apr; 28(4):251-6. PubMed ID: 15259294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
    Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats.
    Wang YL; Wang K; Yu SJ; Li Q; Li N; Lin PY; Li MM; Guo JY
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):389-98. PubMed ID: 25359392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin inhibitor reduces leukocyte-endothelial cell interactions and vascular leakage after scatter laser photocoagulation.
    Musashi K; Kiryu J; Miyamoto K; Miyahara S; Katsuta H; Tamura H; Hirose F; Yoshimura N
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2561-6. PubMed ID: 15980248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
    Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
    Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of pigment epithelium-derived factor delivered by adeno-associated virus inhibits blood-retinal barrier breakdown in diabetic rats.
    Yu H; Chen L; Jiang J
    Mol Vis; 2010 Nov; 16():2384-94. PubMed ID: 21139695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
    Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
    Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2003 Jan; 458(3):283-9. PubMed ID: 12504784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory and antioxidant effects of SERPINA3K in the retina.
    Zhang B; Hu Y; Ma JX
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3943-52. PubMed ID: 19324842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor.
    Jin J; Zhou KK; Park K; Hu Y; Xu X; Zheng Z; Tyagi P; Kompella UB; Ma JX
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6230-7. PubMed ID: 21357401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.